Literature DB >> 15972951

Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.

Dennis Huugen1, Hong Xiao, Anita van Esch, Ronald J Falk, Carine J Peutz-Kootstra, Wim A Buurman, Jan Willem Cohen Tervaert, J Charles Jennette, Peter Heeringa.   

Abstract

Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome, and idiopathic pauci-immune necrotizing crescentic glomerulonephritis are associated with myeloperoxidase (MPO)-specific anti-neutrophil cytoplasmic autoantibodies (ANCAs). Clinical and experimental evidence indicates that ANCA and proinflammatory stimuli of infectious origin act synergistically to cause vasculitis. We tested this hypothesis in a recently developed mouse model of anti-MPO IgG-induced glomerulonephritis by using bacterial lipopolysaccharide (LPS) as the proinflammatory stimulus. Systemic administration of LPS dose dependently increased renal injury induced by anti-MPO IgG as demonstrated by increased glomerular crescent formation and glomerular necrosis. In the early phase, LPS enhanced anti-MPO IgG-induced glomerular neutrophil accumulation. Furthermore, a transient induction of circulating tumor necrosis factor (TNF)-alpha levels, followed by a marked increase in circulating MPO levels, was observed on administration of LPS. In vitro, anti-MPO IgG induced a respiratory burst in murine neutrophils only after priming with TNF-alpha. Finally, anti-TNF-alpha treatment attenuated, but did not prevent, the LPS-mediated aggravation of anti-MPO IgG-induced glomerulonephritis. In conclusion, our study demonstrates that ANCA and proinflammatory stimuli act synergistically to induce vasculitic disease and suggests potential benefits of inhibiting TNF-alpha bioactivity in treating human ANCA-associated necrotizing crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972951      PMCID: PMC1603449          DOI: 10.1016/s0002-9440(10)62952-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils.

Authors:  J H Vernooy; M A Dentener; R J van Suylen; W A Buurman; E F Wouters
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

2.  Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis.

Authors:  Takao Masaki; Fiona Chow; David J Nikolic-Paterson; Robert C Atkins; Gregory H Tesch
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

3.  Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.

Authors:  A M Karkar; J Smith; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  2001-03       Impact factor: 5.992

4.  Relapses in Wegener's granulomatosis: the role of infection.

Authors:  A J Pinching; A J Rees; B A Pussell; C M Lockwood; R S Mitchison; D K Peters
Journal:  Br Med J       Date:  1980-09-27

5.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Authors:  Hong Xiao; Peter Heeringa; Peiqi Hu; Zhi Liu; Minglang Zhao; Yasuaki Aratani; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 6.  Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies.

Authors:  Agnieszka A Rarok; Pieter C Limburg; Cees G M Kallenberg
Journal:  J Leukoc Biol       Date:  2003-07       Impact factor: 4.962

7.  Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

Authors:  Anthony Booth; Lorraine Harper; Tariq Hammad; Paul Bacon; Megan Griffith; Jeremy Levy; Caroline Savage; Charles Pusey; David Jayne
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

8.  Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO.

Authors:  Dominique Reumaux; Martin de Boer; Alexander B Meijer; Patrick Duthilleul; Dirk Roos
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

9.  Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.

Authors:  Won K Han; Hyon K Choi; Rachel M Roth; Robert T McCluskey; John L Niles
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

Review 10.  Does infection play a role in the pathogenesis of pulmonary vasculitis?

Authors:  Stephen A Capizzi; Ulrich Specks
Journal:  Semin Respir Infect       Date:  2003-03
View more
  77 in total

Review 1.  ANCA-associated vasculitides--advances in pathogenesis and treatment.

Authors:  Min Chen; Cees G M Kallenberg
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

Review 2.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 3.  ANCA-associated vasculitides-lessons from the adult literature.

Authors:  Joannis Vamvakopoulos; Caroline O Savage; Lorraine Harper
Journal:  Pediatr Nephrol       Date:  2010-04-01       Impact factor: 3.714

4.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

6.  Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Authors:  Sarah L Nolan; Neena Kalia; Gerard B Nash; Dia Kamel; Peter Heeringa; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

7.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

8.  MicroRNA-155 a new therapeutic target in crescentic GN.

Authors:  Stephen R Holdsworth; Shaun A Summers
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

Review 9.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

10.  C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

Authors:  Adrian Schreiber; Hong Xiao; J Charles Jennette; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.